Your Gut Microbiome and IBD: What You Need to Know

Understanding gut bacteria in IBD

When you’re living with Crohn’s disease or ulcerative colitis, you’ll often hear about the gut microbiome. But what does it actually mean, and why does it matter for inflammatory bowel disease?

What is the gut microbiome?

The gut microbiome is the community of bacteria, fungi, and other tiny organisms that live inside your digestive system. Trillions of these organisms exist in your gut, particularly in the large bowel. Many are helpful, aiding digestion, producing useful substances, and interacting with the immune system.

In a healthy gut, this community is balanced and diverse. Different types of bacteria work together, and no single group dominates. This balance can be disrupted by illness, infection, diet, stress, antibiotics, or inflammation itself.

Why it matters in IBD

In Crohn’s disease and ulcerative colitis, the balance of gut bacteria is often different from what’s seen in people without IBD. Research consistently shows that people with IBD tend to have fewer types of bacteria overall, and the mix present is often altered.

This change may contribute to inflammation in several ways. Some bacteria produce substances that support the gut lining and help regulate the immune system. When these are reduced, the gut may become more vulnerable to inflammation. Other bacteria may become more common, and some can produce substances that may irritate the gut lining or encourage immune activity.

Changes in gut bacteria are not the sole cause of IBD. Crohn’s disease and ulcerative colitis are complex conditions influenced by genetics, the immune system, and environmental factors. However, the gut microbiome appears to play a role in how inflammation develops and persists.

What may be happening in the body

Lower diversity

People with IBD often have fewer different types of bacteria compared to people without IBD. This reduction in variety is associated with more active disease and may make the gut less stable. A more diverse community is generally more resilient and better able to support normal gut function.

Changes in helpful bacteria

Certain bacteria that produce short-chain fatty acids, particularly butyrate, are often reduced in IBD. Butyrate provides energy to gut lining cells and helps regulate immune activity. When these bacteria are less common, the gut lining may not function as well, and inflammation may be harder to control.

Increase in other bacteria

Some bacteria that are usually present in smaller numbers may become more common in IBD. These may produce substances that can irritate the gut or stimulate the immune system in unhelpful ways. The exact mix varies from person to person, but the overall pattern is one of imbalance.

Effects on the gut lining

The gut lining is a thin protective layer separating the contents of the bowel from the rest of the body. Gut bacteria influence how well this lining works. Some bacteria help maintain the protective mucus layer and support the tight connections between cells. When the balance shifts, the gut lining may become more permeable, allowing substances through that would normally be kept out. This can trigger or worsen inflammation.

Interaction with the immune system

The immune system in the gut constantly interacts with bacteria. In a healthy gut, this interaction is balanced, tolerating helpful bacteria and responding appropriately to harmful ones. In IBD, this balance is disrupted. Changes in gut bacteria may influence immune signals in ways that promote inflammation, and ongoing inflammation can further alter the bacterial community, creating a cycle that’s difficult to break.

Can you change your gut microbiome?

Diet, lifestyle, and medication all influence the gut microbiome. However, it’s not yet clear how much control we have over these changes, or whether changing the microbiome directly can reduce inflammation in IBD.

Some dietary approaches, such as eating more fibre, fermented foods, or omega-3 fats, may support a more diverse microbiome. However, these may not suit everyone, particularly during a flare or if certain foods trigger symptoms. What helps one person may not help another, and there is no single diet or supplement that can restore a healthy microbiome in everyone with IBD.

Probiotics are often discussed in the context of gut bacteria. While some have shown modest benefits in specific situations, such as maintaining remission in ulcerative colitis, the evidence is mixed and many products have not been tested in IBD. Discuss any probiotic with your healthcare team before starting it.

Practical takeaways

• The gut microbiome is influenced by what you eat, but changes take time and may not always lead to noticeable symptom improvement.
• If you’re considering dietary changes to support your gut bacteria, it may be helpful to work with a dietitian who understands IBD.
• Probiotics are not all the same, and not all have evidence in IBD. Discuss any probiotic with your doctor or IBD nurse before trying it.
• Symptoms alone don’t tell you whether your gut bacteria are balanced or whether inflammation is present. Regular monitoring with your healthcare team is important.
• Research into the gut microbiome in IBD is ongoing. Future treatments may target gut bacteria more directly, but current medical treatments remain the most effective way to control inflammation.

Conclusion

The gut microbiome is an important part of understanding IBD, but it’s only one part of a complex picture. Changes in gut bacteria are common in Crohn’s disease and ulcerative colitis and may contribute to inflammation, but they are not something you can fully control through diet or lifestyle alone. The most important step is to work with your healthcare team to manage inflammation with appropriate medical treatment, and to discuss any dietary or supplement approaches that interest you.

References

1. Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018;11(1):1-10. doi:10.1007/s12328-017-0813-5

1. Sartor RB, Wu GD. Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches. Gastroenterology. 2017;152(2):327-339. doi:10.1053/j.gastro.2016.10.012

1. Pascal V, Pozuelo M, Borruel N, et al. A microbial signature for Crohn’s disease. Gut. 2017;66(5):813-822. doi:10.1136/gutjnl-2016-313235

1. Lloyd-Price J, Arze C, Ananthakrishnan AN, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569(7758):655-662. doi:10.1038/s41586-019-1237-9

1. Matsuoka K, Kanai T. The gut microbiota and inflammatory bowel disease. Semin Immunopathol. 2015;37(1):47-55. doi:10.1007/s00281-014-0454-4

1. Prossomariti A, Scaioli E, Piazzi G, et al. Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis. Sci Rep. 2017;7(1):7458. doi:10.1038/s41598-017-07992-1

This article is intended for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical guidance, diagnosis, or treatment.